Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul N Span

Showing results (1-10 of 209) with videos related to

Pageof 21
Sort By:
Future Science OA|December 30, 2016
From eels to the importance of cancer biobanksPaul N Span
Cancers|October 17, 2019
The Role of Hypoxia and the Immune System in Tumor RadioresistancePaul N Span, Jan Bussink
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 28, 2015
γ-H2AX foci in peripheral blood lymphocytes to quantify radiation-induced DNA damage after 177Lu-DOTA-octreotate peptide receptor radionuclide therapyJohan Bussink, Paul N Span
Future Science OA|December 30, 2016
International biobanks: do or do not?Paul N Span, Peggy Manders
Seminars in Nuclear Medicine|February 24, 2015
Biology of hypoxiaPaul N Span, Johan Bussink
Advances in Experimental Medicine and Biology|June 22, 2016
Staining Against Phospho-H2AX (γ-H2AX) as a Marker for DNA Damage and Genomic Instability in Cancer Tissues and CellsAnika Nagelkerke, Paul N Span
Clinical and Translational Radiation Oncology|April 28, 2020
The tumor microenvironment and radiotherapy response; a central role for cancer-associated fibroblastsMarleen Ansems, Paul N Span
Frontiers in Oncology|June 2, 2020
Editorial: Advances in Biological Understanding of Tumor Radiation ResistanceIra Ida Skvortsova, Paul N Span
Journal for Immunotherapy of Cancer|March 12, 2021
Letter to the editor: Hypoxia kinetics and histology in combined radiotherapy and oxidative phosphorylation inhibition effects on antitumor immunityDaan F Boreel, Paul N Span, Johan Bussink
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2019
BRAF<sup>V600E</sup> Inhibitor Radiosensitizes Thyroid Cancer-LetterEva-Leonne Göttgens, Katrin Rabold, Paul N Span
Pageof 21

Showing results (1-10 of 209) with videos related to

Sort By:
Pageof 21
Future Science OA|December 30, 2016
From eels to the importance of cancer biobanksPaul N Span
Cancers|October 17, 2019
The Role of Hypoxia and the Immune System in Tumor RadioresistancePaul N Span, Jan Bussink
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 28, 2015
γ-H2AX foci in peripheral blood lymphocytes to quantify radiation-induced DNA damage after 177Lu-DOTA-octreotate peptide receptor radionuclide therapyJohan Bussink, Paul N Span
Future Science OA|December 30, 2016
International biobanks: do or do not?Paul N Span, Peggy Manders
Seminars in Nuclear Medicine|February 24, 2015
Biology of hypoxiaPaul N Span, Johan Bussink
Advances in Experimental Medicine and Biology|June 22, 2016
Staining Against Phospho-H2AX (γ-H2AX) as a Marker for DNA Damage and Genomic Instability in Cancer Tissues and CellsAnika Nagelkerke, Paul N Span
Clinical and Translational Radiation Oncology|April 28, 2020
The tumor microenvironment and radiotherapy response; a central role for cancer-associated fibroblastsMarleen Ansems, Paul N Span
Frontiers in Oncology|June 2, 2020
Editorial: Advances in Biological Understanding of Tumor Radiation ResistanceIra Ida Skvortsova, Paul N Span
Journal for Immunotherapy of Cancer|March 12, 2021
Letter to the editor: Hypoxia kinetics and histology in combined radiotherapy and oxidative phosphorylation inhibition effects on antitumor immunityDaan F Boreel, Paul N Span, Johan Bussink
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2019
BRAF<sup>V600E</sup> Inhibitor Radiosensitizes Thyroid Cancer-LetterEva-Leonne Göttgens, Katrin Rabold, Paul N Span
Pageof 21